newsfilter
← Latest News
Business Wire·

Ipsen Delivers Strong H1 2021 Results and Upgrades Full-Year Guidance

Regulatory News: Ipsen ((Euronext: IPN, OTC:IPSEY), a global specialty-driven biopharmaceutical company, today announced its financial results for the first half of 2021: Strong financial results Total sales growth in H1 2021 of 11.0% at CER